Detalhe da pesquisa
1.
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
N Engl J Med
; 388(16): 1465-1477, 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018468
2.
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
N Engl J Med
; 386(25): 2377-2386, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731653
3.
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
J Infect Dis
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606958
4.
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Older Adults.
Clin Infect Dis
; 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992000
5.
A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults.
J Infect Dis
; 226(12): 2054-2063, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543281
6.
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
J Infect Dis
; 225(12): 2056-2066, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931667
7.
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
J Infect Dis
; 225(8): 1357-1366, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932102
8.
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
Clin Infect Dis
; 67(1): 42-49, 2018 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29324986
9.
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
N Engl J Med
; 372(12): 1114-25, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25785969
10.
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
J Infect Dis
; 212(1): 18-27, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395187
11.
Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.
Clin Infect Dis
; 61(3): 313-23, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870329
12.
An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine.
BMC Pediatr
; 13: 98, 2013 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23786774
13.
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.
Vaccine
; 39(43): 6414-6421, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563397
14.
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence.
Hum Vaccin Immunother
; 16(11): 2758-2772, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32530360
15.
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults.
Hum Vaccin Immunother
; 15(3): 575-583, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30648932
16.
Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial.
Hum Vaccin Immunother
; 15(2): 444-451, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303436
17.
Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.
Hum Vaccin Immunother
; 14(8): 1948-1956, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29543583
18.
Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
Vaccine
; 36(11): 1477-1483, 2018 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29429807
19.
Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
Expert Rev Vaccines
; 17(1): 45-55, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29183235
20.
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Vaccine
; 35(9): 1266-1272, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173960